期刊
MARINE DRUGS
卷 13, 期 8, 页码 4967-4984出版社
MDPI AG
DOI: 10.3390/md13084967
关键词
anti-cancer; drug discovery; JAK; STAT signaling
资金
- Recherches Scientifiques Luxembourg association
- Fondation de Recherche Cancer et Sang
- Een Haerz fir kriibskrank Kanner association
- Action LIONS Vaincre le Cancer association
- Televie Luxembourg
- Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University
- NRF by the MEST of Korea for Tumor Microenvironment GCRC grant [2012-0001184]
- Brain Korea (BK21) PLUS program
Part of our ocean's richness comes from its extensive history of supporting life, resulting in a highly diverse ecological system. To date, over 250,000 species of marine organisms have been identified, but it is speculated that the actual number of marine species exceeds one million, including several hundreds of millions of species of marine microorganisms. Past studies suggest that approximately 70% of all deep-sea microorganisms, gorgonians, and sea sponges produce secondary metabolites with anti-cancer activities. Recently, novel FDA-approved drugs derived from marine sponges have been shown to reduce metastatic breast cancer, malignant lymphoma, and Hodgkin's disease. Despite the fact that many marine natural products have been shown to possess a good inhibition potential against most of the cancer-related cell signaling pathways, only a few marine natural products have been shown to target JAK/STAT signaling. In the present paper, we describe the JAK/STAT signaling pathways found in marine organisms, before elaborating on the recent advances in the field of STAT inhibition by marine natural products and the potential application in anti-cancer drug discovery.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据